Mark Thornton

Mark Thornton currently serves as the Chief Executive Officer of VION Biosciences, a life science company focused on manufacturing critical materials and enabling scientific advancements. Additionally, Mark serves as a Board Member at Nova Molecular Technologies, Inc., and provides executive advisory services at Iron Path Capital. Previously, Mark held senior leadership roles at VWR, overseeing sales application specialists and strategic portfolio management for chemicals and life sciences. Mark's earlier experience includes directorial roles at Amresco and research positions at Cleveland Clinic and Athersys, contributing to significant scientific projects. Mark holds an MBA in Marketing and a BS in Biology from Cleveland State University.